Basecamp Research Launches Trillion Gene Atlas
Analysis based on 12 articles · First reported Mar 18, 2026 · Last updated Mar 18, 2026
The launch of the Trillion Gene Atlas by Basecamp Research, with key partners like NVIDIA, Anthropic, Ultima Genomics, and PacBio, is expected to significantly accelerate AI-driven drug discovery and therapeutic design. This initiative could lead to substantial advancements in biotechnology and pharmaceuticals, positively impacting the stock prices and market sentiment of the involved publicly traded companies and potentially creating new investment opportunities in the biotech AI sector.
Basecamp Research, an AI lab for biological design, has launched the Trillion Gene Atlas, a scientific initiative to generate and model biological data at an unprecedented trillion-gene scale. This project aims to expand known evolutionary genetic diversity 100-fold by collecting genomic data from over 100 million species globally. Collaborating with Anthropic, Ultima Genomics, and PacBio, and powered by NVIDIA AI infrastructure, the initiative seeks to provide vast, diverse training data for AI systems to design new medicines. The Trillion Gene Atlas builds on Basecamp Research's EDEN foundation models, which have already demonstrated capabilities in designing diverse therapeutics and pioneering AI-Programmable Gene Insertion. The project will compress over two decades of biological data gathering and analysis into less than two years, leveraging advanced sequencing technologies and accelerated computing. This endeavor is expected to revolutionize drug design, gene therapy, and the fight against antibiotic-resistant bacteria.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard